Functionotherapeutics: Gene Discovery and Function based Therapeutic Strategies

to   

PROSTATE CANCER, EWING SARCOMA, BREAST CANCER, LUNG CANCER, OVARIAN CANCER, PANCREATIC CANCER

Dr E. Shyam P. Reddy,
Functionotherapeutics,
Professor and Director, Cancer Biology Program, Dept of OB/GYN, Morehouse School of Medicine, 720 Westview Drive
Atlanta, GA 30310
United States

ph: 404-756-5230
fax: 678-623-5999

ereddy@msm.edu

  • Home
  • Discovery of Pri-Micro RNA-Encoded Proteins/ Peptides in mammalian cells
  • Our Novel Prediction that mRNA may function like lncRNA, pri-miRNA or miRNA comes to reality
  • NOVEL THERAPY FOR PROSTATE CANCER
  • About Us
  • HONORS and AWARDS
  • Gene Discovery/Road map to Therapy
  • our achievements
  • LIFETIME ACHIEVEMENT AWARD, Mother Teresa Excellence Award
  • MAHATMA GANDHI PRAVASI GOLD MEDAL
  • Novel Targeted Therapeutic Agents against ERG-positive Prostate Cancer
  • ERG GENE and PROSTATE CANCER
  • ERG Oncogene and TGF beta signaling in Prostate Cancer
  • Anti-epilepsy drug Valproic acid targets ERG-positive Prostate cancers
  • Novel research in Breast Cancer
  • Facts about PROSTATE CANCER
  • BEST PERSONALITIES OF INDIA AWARD, SUPER ACHIEVERS OF INDIA AWARD, BHARAT EXCELLENCE AWARD
  • International Goldstar Award, 2012
  • Bharat Gaurav Award
  • CPDR Saturday Distinguished Visiting Professor
  • TAMA AWARD
  • Services to enrich knowledge and life
  • NOVEL DISCOVERY
  • Contact Us
  • Latest News
  • Latest News Continued
  • BREAKING NEWS
  • KEY WORDS
  • CANCER and Frequently asked questions
  • Discovery of Pri-Micro RNA-Encoded Proteins/ Peptides in mammalian cells.
  • Novel Findings and Discoveries around the world

Discovery of Pri-Micro RNA-Encoded Proteins/ Peptides in mammalian cells.

Thus, these results (proving the existence of pri-miRNA encoded biologically active peptides/proteins in mammalian cells) will revolutionize the biology field per se as they may be involved in growth and development of all humans, animals, plants and other living creatures. Based on our results, we predict that there will be a great number of publications describing novel pri-miRNA encoded peptides/small proteins in mammalian cells will be forthcoming in future that may change the landscape of Biology per se. NIH/NSF/DOD may have to dedicate Billions of Dollars budget for the analysis and study of these novel proteins/peptides.

Dr Reddy and his colleagues at Morehouse School of Medicine has decoded Non-coding DNA (JUNK DNA, 98% of Human Genome) and its non-coding RNA and discovered novel category Pri-Micro RNA-Encoded Proteins/ Peptides in mammalian cells (Importance of these novel miPEPs were reviewed in three reviews shown below). We have shown that Pri-Micro RNA-200a and Pri-Micro RNA-200b encode NOVEL Tumor Suppressors (mi-PEP-200a and mi-PEP-200b) which inhibit migration of Prostate and Breast cancer cells. Recently, we have raised antibodies to miPEP-200s and shown their presence in normal breast and prostate cancer cells (manuscript, in press). One can use these mi-PEPs as biomarkers and precision therapeutic agents to all Human diseases including all Cancers, Alzheimer’s, Parkinson, Cardiovascular diseases (In press) and Pulmonary diseases etc.and also their treatment .

 

This finding suggests that thousands of new/novel functional proteins/peptides are encoded by pri-miRNAs in the mammalian cells. This will revolutionize the future biology, diagnosis and precision therapy. 

 

Our passion is to find a cure to cancer. Nothing great can be achieved without a passion 

 

 

 

"The postings on this site are my own and don't necessarily represent my

organization's positions, strategies or opinions."



 

 

 

Copyright this business. All rights reserved.

Web Hosting by Turbify

 

 

Dr E. Shyam P. Reddy,
Functionotherapeutics,
Professor and Director, Cancer Biology Program, Dept of OB/GYN, Morehouse School of Medicine, 720 Westview Drive
Atlanta, GA 30310
United States

ph: 404-756-5230
fax: 678-623-5999

ereddy@msm.edu